{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T21:19:15Z","timestamp":1771103955424,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.riam.2018.04.004","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T18:11:08Z","timestamp":1549908668000},"page":"37-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antifungal susceptibility of Saccharomyces cerevisiae and therapy in a murine model of disseminated infection"],"prefix":"10.1016","volume":"36","author":[{"given":"Alba","family":"P\u00e9rez-Cantero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katihuska","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Guarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Capilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2018.04.004_bib0140","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00253-015-7255-0","article-title":"Dominance of Saccharomyces cerevisiae in alcoholic fermentation processes: role of physiological fitness and microbial interactions","volume":"100","author":"Albergaria","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.riam.2018.04.004_bib0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","article-title":"European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.riam.2018.04.004_bib0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.copbio.2016.02.033","article-title":"Technology development for natural product biosynthesis in Saccharomyces cerevisiae","volume":"42","author":"Billingsley","year":"2016","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.riam.2018.04.004_bib0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/00365540510026454","article-title":"Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole","volume":"37","author":"Burkhardt","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.riam.2018.04.004_bib0160","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/jac\/dkq171","article-title":"Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species","volume":"65","author":"Calvo","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.riam.2018.04.004_bib0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2008.07.001","article-title":"Comparison of posaconazole and voriconazole in vitro killing against Candida krusei","volume":"62","author":"Cant\u00f3n","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.riam.2018.04.004_bib0170","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijantimicag.2014.06.007","article-title":"Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections","volume":"44","author":"Castanheira","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.riam.2018.04.004_bib0175","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1086\/341567","article-title":"Development of a murine model of cerebral aspergillosis","volume":"186","author":"Chiller","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.riam.2018.04.004_bib0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2141.2012.09212.x","article-title":"Disseminated bread yeast fungaemia in a baker's wife with acute myeloid leukaemia","volume":"158","author":"Choi","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.riam.2018.04.004_bib0185","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition, M27-A3","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.riam.2018.04.004_bib0190","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and safety of probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2018.04.004_bib0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.mycmed.2015.09.004","article-title":"Urinary infection by Saccharomyces cerevisiae: emerging yeast?","volume":"25","author":"Elkhihal","year":"2015","journal-title":"J Mycol Med"},{"key":"10.1016\/j.riam.2018.04.004_bib0200","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/497832","article-title":"Invasive Saccharomyces infection: a comprehensive review","volume":"41","author":"Enache-Angoulvant","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2018.04.004_bib0205","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1128\/AAC.00685-10","article-title":"In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens","volume":"54","author":"Guinea","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2018.04.004_bib0210","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1128\/AAC.41.6.1392","article-title":"Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans","volume":"41","author":"Klepser","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2018.04.004_bib0215","doi-asserted-by":"crossref","first-page":"e98094","DOI":"10.1371\/journal.pone.0098094","article-title":"Pathogenic potential of Saccharomyces strains isolated from dietary supplements","volume":"9","author":"Llopis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.riam.2018.04.004_bib0220","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/cc6843","article-title":"Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin","volume":"12","author":"Lolis","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.riam.2018.04.004_bib0225","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/429916","article-title":"Saccharomyces cerevisiae fungemia: an emerging infectious disease","volume":"40","author":"Mu\u00f1oz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2018.04.004_bib0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.idc.2015.10.012","article-title":"Antifungal agents: spectrum of activity, pharmacology and clinical indications","volume":"30","author":"Nett","year":"2016","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.riam.2018.04.004_bib0235","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01747-08","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2018.04.004_bib0240","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/tid.12384","article-title":"Invasive Saccharomyces cerevisiae in a liver transplant patient: case report and review of infection in transplant recipients","volume":"17","author":"Popiel","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.riam.2018.04.004_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idcr.2016.05.002","article-title":"Saccharomyces cerevisiae osteomyelitis in an immunocompetent baker","volume":"19","author":"Seng","year":"2016","journal-title":"IDCases"},{"key":"10.1016\/j.riam.2018.04.004_bib0250","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1128\/JCM.40.7.2691-2692.2002","article-title":"Fatal Saccharomyces cerevisiae aortic graft infection","volume":"40","author":"Smith","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2018.04.004_bib0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.riam.2013.03.001","article-title":"Saccharomyces cerevisiae infections","volume":"30","author":"Souza Goebel","year":"2013","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.riam.2018.04.004_bib0260","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/mmy.38.3.209.212","article-title":"Effect of grapefruit juice on serum voriconazole concentrations in the mouse","volume":"38","author":"Sugar","year":"2000","journal-title":"Med Mycol"},{"key":"10.1016\/j.riam.2018.04.004_bib0265","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1439-0507.2004.00971.x","article-title":"In vitro activities of voriconazole (UK-109,496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study)","volume":"47","author":"Swinne","year":"2004","journal-title":"Mycoses"},{"key":"10.1016\/j.riam.2018.04.004_bib0270","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/jac\/dkl396","article-title":"Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus","volume":"58","author":"Warn","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S113014061930004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S113014061930004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T06:18:44Z","timestamp":1556691524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S113014061930004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S113014061930004X"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2018.04.004","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal susceptibility of Saccharomyces cerevisiae and therapy in a murine model of disseminated infection","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2018.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Asociaci\u00f3n Espa\u00f1ola de Micolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}